ArticleACS chemical biology2019

Leveraging Atropisomerism to Obtain a Selective Inhibitor of RET Kinase with Secondary Activities toward EGFR Mutants.

Sean T Toenjes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.